BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Rising Glaucoma Prevalence to Spur Advanced Glaucoma Diagnostics Deployment

  Fact.MR, Rockville MD: The glaucoma diagnostics market is anticipated to post substantial gains through 2021 and beyond, as ophthalmic clinics resume elective surgeries in the post-pandemic scenario.

  April 1, 2021

   · 

  5 min read
• Rising Glaucoma Cases to Heighten Iridocorneal Endothelial Syndrome Market Sales: Fact.MR

  Constant improvement in surgical treatment and heavy investment in R&D will stimulate the sales of iridocorneal endothelial syndrome

  April 1, 2021

   · 

  5 min read
• Urine-based Nicotine Testing to Generate Maximum Revenue Pools in Key Regions

  Fact.MR, Rockville MD: Fact.MR’s ongoing nicotine testing market study projects a positive growth trajectory through 2021, with an increasing number of tobacco consumers seeking rehabilitation and cessation approaches.

  April 1, 2021

   · 

  6 min read
• Medical Nonwoven Disposables Market: Innovations in New Materials Help to Bolster Market Growth

  According to the report, the global medical nonwoven disposables market was valued at US$ 14.4 Bn in 2019 and is projected to expand at a CAGR of ~4% from 2020 to 2028.

  April 1, 2021

   · 

  7 min read
• Nose Reconstruction Market | Growing Prevalence of 3D Imaging and Model Reconstruction of Nasal Cartilage

  Nose reconstruction or nose job or rhinoplasty is preformed to change the shape of nose disfigured due to trauma or some birth defects.

  April 1, 2021

   · 

  6 min read
• Hemogenyx Pharmaceuticals PLC Announces CDX Antibody Update

  Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to issue an update on negotiations regarding the future development of its leading product candidate CDX bispecific antibody for the treatment of acute myeloid leukemia.

  April 1, 2021

   · 

  4 min read
• Drug Development

  Yingli Pharma announce promising topline results of a Phase II registration study for treatment of relapsed/refractory follicular lymphoma with the once daily oral PI3KD inhibitor, linperlisib

  Yingli Pharma announce promising topline results of a Phase II registration study for treatment of relapsed/refractory follicular lymphoma with the once daily oral PI3Kδ inhibitor, linperlisib

  April 1, 2021

   · 

  4 min read
• Drug Development

  Celon Pharma Announces CPL’280, Second Generation Oral GPR40 Agonist, Meets Primary Endpoint in Phase 1 Trial

  Celon Pharma S.A. announced the successful completion of a Phase 1 trial of its second generation GPR40 agonist, CPL’280.

  April 1, 2021

   · 

  7 min read
• FDA

  United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

  First and only approved therapy in the United States for patients with PH-ILD, a serious, life-threatening disease with potentially more than 30,000 patients in need

  April 1, 2021

   · 

  11 min read
• Biotech Beach

  Viseon, Inc. Announces International Adoption of the MaxView™ System for Advanced Single-Position Minimally Invasive Spine Surgery Procedures

  Viseon, Inc., a leader in minimally invasive spine surgery visualization technologies, announced MaxView™ international adoption, enabling state-of-the-art single-position lateral access lumbar spine surgery.

  April 1, 2021

   · 

  2 min read